3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
128
Brain Neoplasms
114
Prostatic Neoplasms
101
Neoplasm Metastasis
83
Lung Neoplasms
71
Carcinoma, Hepatocellular
71
Pancreatic Neoplasms
67
Breast Neoplasms
47
Melanoma
44
Carcinoma, Renal Cell
36
Neoplasms
33
Colorectal Neoplasms
26
Squamous Cell Carcinoma of Head and Neck
25
Glioblastoma
24
Liver Neoplasms
20
Head and Neck Neoplasms
16
Small Cell Lung Carcinoma
15
Sarcoma
13
Glioma
12
Kidney Neoplasms
11
Urinary Bladder Neoplasms
9
Recurrence
9
Gliosarcoma
8
Ovarian Neoplasms
7
Adenocarcinoma of Lung
7
Adenocarcinoma
7
Prostate Cancer Metastatic
6
Cholangiocarcinoma
6
Central Nervous System Neoplasms
6
Uveal Melanoma
5
Interventions
Radiotherapy
3
Cisplatin
3
Fluorouracil
2
tislelizumab
1
pembrolizumab
1
motexafin gadolinium
1
Tamoxifen
1
Talaporfin
1
TP protocol
1
Spinal Puncture
1
Rhenium
1
Radiosurgery
1
Poly I-C
1
Paclitaxel
1
Oxaliplatin
1
Mitomycin
1
Lomustine
1
Irinotecan
1
Gemcitabine
1
Folfox protocol
1
Ethiodized Oil
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cetuximab
1
Carboplatin
1
Blood Specimen Collection
1
Bevacizumab
1
Anesthesia, General
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasm Recurrence, Local
×
Radiosurgery
×
Clear all
NCT01594892
2019-09-04
DOSIS
Wuerzburg University Hospital
Phase NA
Completed
60 enrolled